Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K/A, Date: 2016-01-11
Original SEC Filing: Click here

---

Webplus: TPI/20160111/8-K.A/2_EX-99.1/000.htm SEC Original: f8k010516a1ex99i_tianyin.htm
TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the “Company”), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received a plan acceptance letter (the “Plan Acceptance Letter”) on January 5, 2016 from the

---

---

Webplus: TPI/20160111/8-K.A/1/000.htm SEC Original: f8k010516a1_tianyinpharma.htm

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K/A, Date: 2016-01-11CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041